DNA methylation in the pathogenesis of type 2 diabetes in humans
Background: Type 2 diabetes (T2D) is a multifactorial, polygenic disease caused by impaired insulin secretion and insulin resistance. Genome-wide association studies (GWAS) were expected to resolve a large part of the genetic component of diabetes; yet, the single nucleotide polymorphisms identified...
Saved in:
Main Authors: | Cajsa Davegårdh (Author), Sonia García-Calzón (Author), Karl Bacos (Author), Charlotte Ling (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The potential DNA methylation markers of cardiovascular disease in patients with type 2 diabetes
by: Yunbiao He, et al.
Published: (2023) -
Contribution of DNA methylation to the pathogenesis of Sjögren's syndrome: A review
by: Juliana Ramalho Guimarães, et al.
Published: (2022) -
Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes
by: Meriem Ouni, et al.
Published: (2023) -
Genome-wide DNA promoter methylation and transcriptome analysis in human adipose tissue unravels novel candidate genes for obesity
by: Maria Keller, et al.
Published: (2017) -
Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus
by: Beck Stephan, et al.
Published: (2010)